Noninvasive 3-D optical quantitative imaging of engineered tissue
Award amount
$149,991Program and phase
SBIR · Phase IAward year
2012Award details
- Awarding agency
- Department of Defense
- Branch
- Defense Health Agency
- Recipient company
- DIAGNOSTIC PHOTONICS, INC.
- Proposal award date
- 2012-01-01
- Contract end date
- Not reported
- UEI
- FNDNUZEMPST3
- Solicitation number
- 2011.2
- Topic code
- OSD11-H08
Research abstract
Technology keywords
Not reported
Other awards by this recipient
Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.
- IGF::OT::IGF
- Pharmacological Targeting of Endothelial Dysfunction in Atherogenesis
- Computed Optical Margin Assessment for Breast Cancer
- Computed Optical Margin Assessment for Breast Cancer
- IGF::OT::IGF OTHER FUNCTIONS AUTOMATED DATA SEGMENTATION TO ENABLE REAL-TIME IN VIVO 3-D IMAGE RECONSTRUCTION
Awards with the same topic code
Verified by an exact topic code match. This is not a text-similarity match.
- High-resolution optical imaging and spectroscopy instrument for real-time characterization of soft tissue constructs
- 3-D Morphology and Viability Status Imaging of Tissue Culture
- Real-time Assessment of Engineered Tissue Viability with Combined Raman SpectroscopyHigh Resolution Optical Imaging
- Real Time Multidimensional Spectroscopic Assessment of Tissue Viability
Research funding history
6 SBIR/STTR records share this UEI (2012–2014). Reported award amounts total $3,648,916. Reported amounts are not federal obligations.
Phases: Phase I, Phase II
Agencies: Department of Health and Human Services, Department of Defense